These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 21477640

  • 1. Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanism.
    Xiong W, Koo BN, Morton R, Zhang L.
    Neuroscience; 2011 Jun 16; 184():28-37. PubMed ID: 21477640
    [Abstract] [Full Text] [Related]

  • 2. The effect of Δ9-tetrahydrocannabinol on 5-HT3 receptors depends on the current density.
    Yang KH, Isaev D, Morales M, Petroianu G, Galadari S, Oz M.
    Neuroscience; 2010 Nov 24; 171(1):40-9. PubMed ID: 20800662
    [Abstract] [Full Text] [Related]

  • 3. The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes.
    Yang KH, Galadari S, Isaev D, Petroianu G, Shippenberg TS, Oz M.
    J Pharmacol Exp Ther; 2010 May 24; 333(2):547-54. PubMed ID: 20160007
    [Abstract] [Full Text] [Related]

  • 4. Δ9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats.
    Silveira MM, Adams WK, Morena M, Hill MN, Winstanley CA.
    J Psychiatry Neurosci; 2017 Mar 24; 42(2):131-138. PubMed ID: 28245177
    [Abstract] [Full Text] [Related]

  • 5. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
    Hindelang P, Scharinger A, Richling E, Walch SG, Lachenmeier DW.
    Front Biosci (Landmark Ed); 2022 Jul 25; 27(8):228. PubMed ID: 36042166
    [Abstract] [Full Text] [Related]

  • 6. Cannabidiol Interferes with Establishment of Δ9-Tetrahydrocannabinol-Induced Nausea Through a 5-HT1A Mechanism.
    DeVuono MV, La Caprara O, Petrie GN, Limebeer CL, Rock EM, Hill MN, Parker LA.
    Cannabis Cannabinoid Res; 2022 Feb 25; 7(1):58-64. PubMed ID: 33998876
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol.
    Ross HR, Napier I, Connor M.
    J Biol Chem; 2008 Jun 06; 283(23):16124-34. PubMed ID: 18390906
    [Abstract] [Full Text] [Related]

  • 8. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
    Sainz-Cort A, Jimenez-Garrido D, Muñoz-Marron E, Viejo-Sobera R, Heeroma J, Bouso JC.
    J Clin Psychopharmacol; 2008 Jun 06; 41(5):561-570. PubMed ID: 34412109
    [Abstract] [Full Text] [Related]

  • 9. Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure.
    Miller S, Daily L, Leishman E, Bradshaw H, Straiker A.
    Invest Ophthalmol Vis Sci; 2018 Dec 03; 59(15):5904-5911. PubMed ID: 30550613
    [Abstract] [Full Text] [Related]

  • 10. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
    Hindocha C, Freeman TP, Schafer G, Gardener C, Das RK, Morgan CJ, Curran HV.
    Eur Neuropsychopharmacol; 2015 Mar 03; 25(3):325-34. PubMed ID: 25534187
    [Abstract] [Full Text] [Related]

  • 11. Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization.
    Xiong W, Hosoi M, Koo BN, Zhang L.
    Mol Pharmacol; 2008 Feb 03; 73(2):314-22. PubMed ID: 17993512
    [Abstract] [Full Text] [Related]

  • 12. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L, Mata M, Alcacer J, Oliver M, Sancho-Tello M, Martín de Llano JJ, Camps C, Galbis J, Carretero J, Carda C.
    PLoS One; 2020 Feb 03; 15(2):e0228909. PubMed ID: 32049991
    [Abstract] [Full Text] [Related]

  • 13. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T.
    Int J Neuropsychopharmacol; 2010 Aug 03; 13(7):861-76. PubMed ID: 19785914
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
    Klein C, Karanges E, Spiro A, Wong A, Spencer J, Huynh T, Gunasekaran N, Karl T, Long LE, Huang XF, Liu K, Arnold JC, McGregor IS.
    Psychopharmacology (Berl); 2011 Nov 03; 218(2):443-57. PubMed ID: 21667074
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.